Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia

Schizophrenia Research

Volumn 87, Issue 1-3, 2006, Pages 332-333

  Hashimoto, K ^a   Motomura, H ^b   Sudo, T ^a   Tagawa, K ^c   Nashiro, S ^d   Uemura, K ^e   Yoshimoto, S ^f   Hirano, M ^a  

^a National Hospital Organization Hizen Psychiatric Center   (Japan)

^b Yahata Kosei Hospital   (Japan)

^c Mitate Hospital   (Japan)

^d Okinawa Chuo Hospital   (Japan)

^e Kouno Hospital   (Japan)

^f FUJITSU LABORATORIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT; ZOTEPINE;

ADULT; APATHY; BODY POSTURE; CLINICAL ARTICLE; CONCEPT ANALYSIS; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; EMOTION; EXCITEMENT; FEMALE; GESTURE; HOSTILITY; HUMAN; LETTER; MALE; MOTOR RETARDATION; OPEN STUDY; PARAMETERS OF MEASUREMENT AND ANALYSIS; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; STEREOTYPY; TREATMENT OUTCOME; WILCOXON SIGNED RANKS TEST;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIEPINS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 33748912039     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.03.048     Document Type: Letter

References (6)

1. Barnas C., Stuppack C.H., Miller C., et al. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs haloperidol. Int. Clin. Psychopharmacol. 7 (1992) 23-27
2. Gresch P.J., Sved A.F., Zigmond M.J., et al. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem. 65 (1995) 111-116
3. Inada T. Evaluation and Diagnosis of Drug-Induced Extrapyramidal Symptoms: Commentary on the DIEPSS and Guide to Its Usage (1996), Seiwa Shoten, Tokyo 25-39
4. Meyer-Lindenberg A., Gruppe H., Bauer U., et al. Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study. Pharmacopsychiatry 30 (1997) 35-42
5. Rowley H.L., Needham P.L., Kilpatrick I.C., et al. A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 361 (2000) 187-192
6. Tatsumi M., Jansen K., Blakely R.D., et al. Pharmacological profile of neuroleptics at human monoamine transporters. Eur. J. Pharmacol. 368 (1999) 277-283